
News|Articles|March 17, 2026
Challenging Cases®: Firsthand insight into oncology decision‑making
Through interactive, quantitative live and virtual double-blinded case-based sessions followed by a national key opinion leader data-focused discussion, Challenging Cases offers a window into how oncologists select treatment options, balance clinical considerations, and respond to complex patient scenarios, providing insight into the factors shaping real-world treatment decisions.
Related Content
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
What Pharma Investors Should Expect in the Current Regulatory Environment
5